Abstract:The development of injectable integrin alpha(v)beta(3)/alpha(IIb)beta(3) dual antagonists attracts much attention of research for treating of acute ischemic diseases in recent years. In this work, based on a dataset composed of 102 tricyclic piperazine/piperidine furnished dual alpha(v)beta(3) and alpha(IIb)beta(3) antagonists, a variety of in silico modeling approaches including the comparative molecular field analysis (CoMFA), comparative similarity indices analysis (CoMSIA), and molecular docking were applied to reveal the requisite 3D structural features impacting the biological activities. Our statistical results show that the ligand-based 3D-QSAR models for both the alpha(v)beta(3) and alpha(IIb)beta(3) studies exhibited satisfactory internal and external predictability, i.e., for the CoMFA models, results of Q(2) = 0.48, R-ncv(2) = 0.87, R-pred(2) = 0.71 for alpha(v)beta(3) and Q(2) = 0.50, R-ncv(2) = 0.85, R-pred(2) = 0.72 for alpha(IIb)beta(3) analysis were obtained, and for the CoMSIA ones, the outcomes of Q(2) = 0.55, R-ncv(2) = 0.90, R-pred(2) = 0.72 for alpha(v)beta(3) and Q(2) = 0.52, R-ncv(2) = 0.88, R-pred(2) = 0.74 for alpha(IIb)beta(3) were achieved respectively. In addition, through a comparison between 3D-QSAR contour maps and docking results, it is revealed that that the most crucial interactions occurring between the tricyclic piperazine/piperidine derivatives and alpha(v)beta(3)/alpha(IIb)beta(3) receptor ligand binding pocket are H-bonding, and the key amino acids impacting the interactions are Arg214, Asn215, Ser123, and Lys253 for alpha(v)beta(3), but Arg214, Asn215, Ser123 and Tyr190 for alpha(IIb)beta(3) receptors, respectively. Halogen-containing groups at position 15 and 16, benzene sulfonamide substituent at position 23, and the replacement of piperazine with 4-aminopiperidine of ring B may increase the alpha(v)beta(3)/alpha(IIb)beta(3) antagonistic activity. The potencies for antagonists to inhibit isolated alpha(v)beta(3) and alpha(IIb)beta(3) are linear correlated, indicating that similar interaction mechanisms may exist for the series of molecules. To our best knowledge this is the first report on 3D-QSAR modeling of these dual alpha(v)beta(3)/alpha(IIb)beta(3) antagonists. The results obtained should provide information for better understanding of the mechanism of antagonism and thus be helpful in design of novel potent dual alpha(v)beta(3)/alpha(IIb)beta(3) antagonists. (C) 2011 Elsevier Inc. All rights reserved.

Studies of Tricyclic Piperazine/piperidine Furnished Molecules As Novel Integrin Αvβ3/αiibβ3 Dual Antagonists Using 3D-QSAR and Molecular Docking.

2D-QSAR studies of integrin αvβ3 antagonists

X-ray Crystallography, DFT Calculations and Molecular Docking of Indole-Arylpiperazine Derivatives As Α1a-Adrenoceptor Antagonists

Molecular modeling studies on the selectivity of 4-benzylpiperidine antagonists for hCCR3

Structure-based 3D-QSAR studies on heteroarylpiperazine derivatives as 5-HT3 receptor antagonists.

Investigation on Quantitative Structure Activity Relationships and Pharmacophore Modeling of a Series of Mglur2 Antagonists

3D-QSAR Study on 2,3-Dihydroimidazo[4,5]-pyridin-2-one Derivatives with a Meta Substitution Pattern As V600E BRAF Inhibitors

Studies of H4R Antagonists Using 3D-QSAR, Molecular Docking and Molecular Dynamics

Synthesis, Crystal Structure, Biological Evaluation, and Molecular Docking Studies of Quinoline-Arylpiperazine Derivative As Potent Α1a-Adrenoceptor Antagonist

Design, Synthesis And 3d-Qsar Study Of 2-[N '-(2-Aryloxyethyl)Piperazinomethyl]-Benzoxazole Series As Alpha(1)-Adrenoceptor Antagonists

Virtual identification of novel peroxisome proliferator-activated receptor (PPAR) α/δ dual antagonist by 3D-QSAR, molecule docking and molecule dynamics simulation.

Mechanism Exploration of Arylpiperazine Derivatives Targeting the 5-HT 2A Receptor by In Silico Methods.

Binding Investigation of Integrin Αvβ3 with Its Inhibitors by SPR Technology and Molecular Docking Simulation

Pharmacophore modeling and 3D-QSAR analysis of phosphoinositide 3-kinase p110alpha inhibitors.

Studies of New Fused Benzazepine As Selective Dopamine D3 Receptor Antagonists Using 3D-QSAR, Molecular Docking and Molecular Dynamics

3D-QSAR and Docking Studies of Piperidine Carboxamide Derivatives As ALK Inhibitors

Combined 3D-QSAR modeling and molecular docking study on quinoline derivatives as inhibitors of P-selectin.

Computational Studies of the Binding Site of Α 1A -Adrenoceptor Antagonists

Design, Synthesis and Biological Activities of Piperidine-Spirooxadiazole Derivatives As Α7 Nicotinic Receptor Antagonists

Molecular simulation of a series of benzothiazole PI3Kα inhibitors: probing the relationship between structural features, anti-tumor potency and selectivity

Structural Analysis of (S)-1-((1h-benzo[d][1,2,3]triazol-1-yl)oxy)-3-(4-(2-methoxyphenyl)piperazin-1-yl)propan-2-ol and Binding Mechanism with Α1a-Adrenoceptor: TDDFT Calculations, X-ray Crystallography and Molecular Docking